SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
355.50    5.50 (1.57%)
Bid:
354.00
Ask:
358.00
Spread: 4.00 (1.13%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Interim Management Statement

6 Jul 2012 10:49

RNS Number : 1010H
Caledonia Investments PLC
06 July 2012
 



 

 

 

Caledonia Investments plc

Interim Management Statement for the quarter ended 30 June 2012

 

Caledonia Investments plc ("Caledonia" or the "Company") is one of the UK's largest investment trusts and is self-managed. It aims to be a core investment for those seeking a store of increasing value and an increasing dividend, by investing for the longer term in a range of assets.

 

Caledonia presents its interim management statement for the quarter ended 30 June 2012 and up to the date of publication.

 

 

Material events

 

o

Investments during the period totalled £20.9m, including a further £5.5m through the Quoted pool in Spirax-Sarco Engineering, a UK listed steam engineering company.

o

Realisations during the period totalled £52.0m, including £10.7m from the sale of part of the Company's holding in British Empire Securities, the UK listed investment trust, £8.3m from the sale of the Company's holding in Tribal Group, the UK listed provider of technology and other services to the education sector, and £6.9m from the sale of the Company's holding in Bioquell, the UK listed supplier of medical equipment.

o

Investments and realisations included £6.7m and £11.2m respectively for rebalancing of the Income & Growth pool. The total value of the Company's investments in global large and mid-cap equity securities through this pool at 30 June 2012 was £103.8m. This pool will continue to be dynamically managed to maximise returns.

o

During the quarter ended 30 June 2012, the Company acquired 132,500 of its own shares for cancellation at a cost of £1.8m. Since that date, the Company has purchased a further 30,000 of its own shares for cancellation at a cost of £0.4m. These shares were bought at an average discount to NAV of 28.1%, thus benefitting NAV per share.

o

A final dividend of 31.2p per share was proposed on 24 May 2012, an increase of 20.0% over last year. Subject to approval by shareholders at the annual general meeting to be held on 25 July 2012, the dividend, totalling £17.8m, will be paid on 9 August 2012 to holders of ordinary shares on the register on 6 July 2012. The ex-dividend date was 4 July 2012.

 

 

Financial position and performance summary

 

At 30 Jun 2012 

At 31 Mar 2012 

Net assets

£1,102m 

£1,134m 

NAV per share

1918p 

1977p 

Share price

1422p 

1486p 

Discount

25.9% 

24.8% 

FTSE All-Share index

2891 

3003 

1.

NAVs per share are calculated on a diluted, cum-income basis.

2.

30 June 2012 was the latest date on which an NAV per share was prepared.

 

At 30 June 2012, the Company had £24.0m of cash and £25.0m of debt, compared with £8.4m of cash and £45.0m of debt at 31 March 2012. The debt was drawn on the Company's £100m of committed term bank facilities through two bilateral agreements for £50m revolving credit facilities with ING and The Royal Bank of Scotland, expiring in July 2013. The company also has an overdraft facility of £10m, which was undrawn.

 

 

Investment portfolio

 

Ten largest holdings as at 30 June 2012

Name

Business

£m 

% 

Close Brothers

Financial services

142.2 

12.6 

Cobehold

Investment company

84.9 

7.5 

Bristow Group

Helicopter services

63.5 

5.6 

Avanti Communications

Satellite communications

49.4 

4.4 

AG Barr

Soft drinks

40.9 

3.6 

British Empire Securities

Investment trust

37.4 

3.3 

London & Stamford Property

Property investment

37.4 

3.3 

Oval

Insurance broking

32.2 

2.9 

Satellite Information Services

Broadcasting services

29.8 

2.7 

Capital Today China

Private equity funds

29.5 

2.6 

547.2 

48.5 

Other investments

568.7 

50.5 

Cash and other items

11.1 

1.0 

Total assets

1,127.0 

100.0 

Borrowings

(25.0)

Net assets

1,102.0 

 

Sources: Caledonia Investments plc and FTSE International Limited ('FTSE') © FTSE 2012. 'FTSE®' is a trade mark of the London Stock Exchange Group companies and is used by FTSE International Limited under licence. All rights in the FTSE indices and/or FTSE ratings vest in FTSE and/or its licensors. Neither FTSE nor its licensors accept any liability for any errors or omissions in the FTSE indices and/or FTSE ratings or underlying data. No further distribution of FTSE Data is permitted without FTSE's express written consent.

 

 

Enquiries

 

Caledonia Investments plc

Will Wyatt (Chief Executive)

Stephen King (Finance Director)

Tel: +44 20 7802 8080

 

College Hill

Tony Friend

Antonia Coad

Tel: +44 20 7457 2020

 

6 July 2012

 

END

 

Caledonia publishes monthly fact sheets, which give further details of the investment and other activities during each month. These fact sheets and other information are available on the Company's website at www.caledonia.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSKQLBBLDFZBBD
Date   Source Headline
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 202610:30 amRNSDirector/PDMR Shareholding
29th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSFunds spotlight event
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 202611:36 amRNSDirector/PDMR Shareholding
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 202611:00 amRNSAppointment of non-executive director
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20263:00 pmRNSDirector/PDMR Shareholding
12th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSNet Asset Value(s)
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
24th Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares
16th Dec 20251:36 pmRNSDirector/PDMR Shareholding
9th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 202511:00 amRNSNet Asset Value(s)
3rd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSTotal Voting Rights
28th Nov 20255:04 pmRNSDirector/PDMR Shareholding
28th Nov 20252:51 pmRNSDirector/PDMR Shareholding
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 202512:42 pmRNSIrrevocable Share Repurchase Instruction
25th Nov 20257:00 amRNSHalf-year Financial Report
25th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20257:00 amRNSNotice of half-year results
18th Nov 20257:00 amRNSTransaction in Own Shares
17th Nov 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.